Skip to content

Tarsus Pharmaceuticals, Inc. TARS Annual increase in rent (as a percent)

Annual increase in rent (as a percent) at other companies

Caesars Entertainment, Inc. logo
Caesars Entertainment, Inc.CZR
25.3%0.0pp
FCP
Four Corners Property TrustFCPT
$778K+7.2%
Regency Centers logo
Regency CentersREG
$402.61M+8.5%
New York Mortgage Trust logo
New York Mortgage TrustADAM
$12.63M-28.0%
NNN REIT logo
NNN REITNNN
$1.29M+154%
Omega Healthcare Investors logo
Omega Healthcare InvestorsOHI
$270.62M+16.6%

Other financials

Income statement

See full
Revenue$162.1M+107%
Gross profit$152.7M+109%
Operating income-$6.1M+76.7%
Net income-$7.0M+72.3%
EPS (diluted)-$0.16+75.0%

Balance sheet

See full
Cash & equivalents$104.2M-41.6%
Total debt$88.7M+22.5%
Total equity$349.0M+1.9%
Total assets$581.1M+16.1%

Cash flow

See full
Operating cash flow-$24.7M-19.4%
CapEx$5.8M+886%
Free cash flow-$30.5M-43.4%

Valuation

See full
Market cap$2.85B+41.1%
Enterprise value$2.83B+47.8%
P/S5.3×-3.3×

Profitability

See full
Gross margin42.7%
Operating margin-9.5%-4.2pp
Net margin-9%-4.0pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-14%-5.2pp
Debt / equity0.3×0.0×
Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept tars:LesseeOperatingLeaseAnnualRentIncreasePercent.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s annual increase in rent (as a percent).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s annual increase in rent (as a percent)?
Tarsus Pharmaceuticals, Inc. (TARS) reported annual increase in rent (as a percent) of 3% in Q4 2024.
What does annual increase in rent (as a percent) mean?
This percentage represents the contractual annual escalation rate applied to lease payments over the term of the agreement. It is a critical factor in forecasting future operating expenses and assessing the long-term impact of inflation on facility costs.